318 related articles for article (PubMed ID: 10652192)
21. Peptidase activities in rats treated chronically with N(omega)-nitro-L-arginine methyl ester (L-NAME).
Linardi A; Panunto PC; Ferro ES; Hyslop S
Biochem Pharmacol; 2004 Jul; 68(2):205-14. PubMed ID: 15193992
[TBL] [Abstract][Full Text] [Related]
22. Renal synthesis of urokinase type-plasminogen activator, its receptor, and plasminogen activator inhibitor-1 in diabetic nephropathy in rats: modulation by angiotensin-converting-enzyme inhibitor.
Kenichi M; Masanobu M; Takehiko K; Shoko T; Akira F; Katsushige A; Takashi H; Yoshiyuki O; Shigeru K
J Lab Clin Med; 2004 Aug; 144(2):69-77. PubMed ID: 15322501
[TBL] [Abstract][Full Text] [Related]
23. Effect of imidapril on myocardial remodeling in L-NAME-induced hypertensive rats is associated with gene expression of NOS and ACE mRNA.
Kobayashi N; Hara K; Watanabe S; Higashi T; Matsuoka H
Am J Hypertens; 2000 Feb; 13(2):199-207. PubMed ID: 10701821
[TBL] [Abstract][Full Text] [Related]
24. Regression by ACE inhibition of arteriosclerotic changes induced by chronic blockade of NO synthesis in rats.
Katoh M; Egashira K; Kataoka C; Usui M; Koyanagi M; Kitamoto S; Ohmachi Y; Takeshita A; Narita H
Am J Physiol Heart Circ Physiol; 2001 May; 280(5):H2306-12. PubMed ID: 11299235
[TBL] [Abstract][Full Text] [Related]
25. Renin-angiotensin blockade improves renal cGMP production via non-AT(2)-receptor mediated mechanisms in hypertension-induced by chronic NOS inhibition in rat.
Uhlenius N; Vuolteenaho O; Tikkanen I
J Renin Angiotensin Aldosterone Syst; 2001 Dec; 2(4):233-9. PubMed ID: 11881129
[TBL] [Abstract][Full Text] [Related]
26. Differential subcellular actions of ACE inhibitors and AT(1) receptor antagonists on cardiac remodeling induced by chronic inhibition of NO synthesis in rats.
Sanada S; Kitakaze M; Node K; Takashima S; Ogai A; Asanuma H; Sakata Y; Asakura M; Ogita H; Liao Y; Fukushima T; Yamada J; Minamino T; Kuzuya T; Hori M
Hypertension; 2001 Sep; 38(3):404-11. PubMed ID: 11566913
[TBL] [Abstract][Full Text] [Related]
27. Effects of captopril on cardiac and renal damage, and metabolic alterations in the nitric oxide-deficient hypertensive rat.
Khattab MM; Mostafa A; Al-Shabanah O
Kidney Blood Press Res; 2005; 28(4):243-50. PubMed ID: 16220007
[TBL] [Abstract][Full Text] [Related]
28. Role of angiotensin-converting enzyme 2 in cardiac hypertrophy induced by nitric oxide synthase inhibition.
Inaba S; Iwai M; Furuno M; Kanno H; Senba I; Okayama H; Mogi M; Higaki J; Horiuchi M
J Hypertens; 2011 Nov; 29(11):2236-45. PubMed ID: 21946695
[TBL] [Abstract][Full Text] [Related]
29. Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide-deficiency-induced hypertension in rats.
García-Estañ J; Ortiz MC; O'Valle F; Alcaraz A; Navarro EG; Vargas F; Evangelista S; Atucha NM
Clin Sci (Lond); 2006 Feb; 110(2):227-33. PubMed ID: 16197366
[TBL] [Abstract][Full Text] [Related]
30. Impairment of smooth muscle function of rat thoracic aorta in an endothelium-independent manner by long-term administration of N(G)-nitro-L-arginine methyl ester.
López RM; Ortíz CS; Ruíz A; Vélez JM; Castillo C; Castillo EF
Fundam Clin Pharmacol; 2004 Dec; 18(6):669-77. PubMed ID: 15548238
[TBL] [Abstract][Full Text] [Related]
31. Low doses of ethanol decrease the activity of the angiotensin-converting enzyme in the aorta of aging rats and rats treated with a nitric oxide synthase inhibitor and dexamethasone.
Emel'yanov MO; Korystova AF; Kublik LN; Levitman MKh; Shaposhnikova VV; Korystov YN
Clin Sci (Lond); 2012 Jan; 122(2):75-81. PubMed ID: 21767262
[TBL] [Abstract][Full Text] [Related]
32. [The influence of I/D polymorphism of the angiotensin I converting enzyme (ACE) gene and 4G/5G polymorphism of plasminogen activator inhibitor (PAI-1) gene promoter on the haemostatic system in patients with essential hypertension and dyslipidemia].
Nowakowska A
Ann Acad Med Stetin; 2005; 51(1):95-105. PubMed ID: 16496609
[TBL] [Abstract][Full Text] [Related]
33. Imidapril, an angiotensin-converting enzyme inhibitor, inhibits thrombosis via reduction in aortic plasminogen activator inhibitor type-1 levels in spontaneously hypertensive rats.
Mitsui T; Chishima S; Odawara A; Ohtani A
Biol Pharm Bull; 1999 Aug; 22(8):863-5. PubMed ID: 10480327
[TBL] [Abstract][Full Text] [Related]
34. ET(A) receptor antagonist ameliorates nephrosclerosis and left ventricular hypertrophy induced in rat by prolonged inhibition of nitric oxide synthesis.
Nakamura T; Kurashina T; Saito Y; Sumino H; Akuzawa N; Aizawa H; Sakamoto H; Ono Z; Nagai R
Hypertens Res; 1998 Dec; 21(4):251-7. PubMed ID: 9877518
[TBL] [Abstract][Full Text] [Related]
35. Effects of certain vasoactive agents on the long-term pattern of blood pressure, heart rate, and motor activity in cats.
Brown SA; Langford K; Tarver S
Am J Vet Res; 1997 Jun; 58(6):647-52. PubMed ID: 9185974
[TBL] [Abstract][Full Text] [Related]
36. Salutary effects of attenuation of angiotensin II on coronary perivascular fibrosis associated with insulin resistance and obesity.
Zaman AK; Fujii S; Goto D; Furumoto T; Mishima T; Nakai Y; Dong J; Imagawa S; Sobel BE; Kitabatake A
J Mol Cell Cardiol; 2004 Aug; 37(2):525-35. PubMed ID: 15276022
[TBL] [Abstract][Full Text] [Related]
37. Angiotensin II increases plasminogen activator inhibitor-1 and tissue factor mRNA expression without changing that of tissue type plasminogen activator or tissue factor pathway inhibitor in cultured rat aortic endothelial cells.
Nishimura H; Tsuji H; Masuda H; Nakagawa K; Nakahara Y; Kitamura H; Kasahara T; Sugano T; Yoshizumi M; Sawada S; Nakagawa M
Thromb Haemost; 1997 Jun; 77(6):1189-95. PubMed ID: 9241756
[TBL] [Abstract][Full Text] [Related]
38. Relationship between serum angiotensin-converting enzyme activity and plasma plasminogen activator inhibitor activity in patients with recent myocardial infarction.
Moriyama Y; Ogawa H; Oshima S; Arai H; Takazoe K; Shimomura H; Hirai N; Suefuji H; Soejima H; Nishiyama K; Misumi K; Yasue H
Coron Artery Dis; 1998; 9(10):691-6. PubMed ID: 9894621
[TBL] [Abstract][Full Text] [Related]
39. Plasminogen activator inhibitor-1 deficiency prevents hypertension and vascular fibrosis in response to long-term nitric oxide synthase inhibition.
Kaikita K; Fogo AB; Ma L; Schoenhard JA; Brown NJ; Vaughan DE
Circulation; 2001 Aug; 104(7):839-44. PubMed ID: 11502712
[TBL] [Abstract][Full Text] [Related]
40. Long-term treatment with N(omega)-nitro-L-arginine methyl ester causes arteriosclerotic coronary lesions in endothelial nitric oxide synthase-deficient mice.
Suda O; Tsutsui M; Morishita T; Tanimoto A; Horiuchi M; Tasaki H; Huang PL; Sasaguri Y; Yanagihara N; Nakashima Y
Circulation; 2002 Sep; 106(13):1729-35. PubMed ID: 12270870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
